141 related articles for article (PubMed ID: 8586971)
1. Spectroscopic study of the interaction of aluminum ions with human transferrin.
Tang S; MacColl R; Parsons PJ
J Inorg Biochem; 1995 Nov; 60(3):175-85. PubMed ID: 8586971
[TBL] [Abstract][Full Text] [Related]
2. Competition between Al
Ott DB; Hartwig A; Stillman MJ
Metallomics; 2019 May; 11(5):968-981. PubMed ID: 30916671
[TBL] [Abstract][Full Text] [Related]
3. Interaction of imatinib mesylate with human serum transferrin: The comparative spectroscopic studies.
Śliwińska-Hill U
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Feb; 173():468-475. PubMed ID: 27718450
[TBL] [Abstract][Full Text] [Related]
4. Transferrin binding of Al3+ and Fe3+.
Martin RB; Savory J; Brown S; Bertholf RL; Wills MR
Clin Chem; 1987 Mar; 33(3):405-7. PubMed ID: 3815806
[TBL] [Abstract][Full Text] [Related]
5. Investigation on the interaction between tamoxifen and human holo-transferrin: determination of the binding mechanism by fluorescence quenching, resonance light scattering and circular dichroism methods.
Sarzehi S; Chamani J
Int J Biol Macromol; 2010 Nov; 47(4):558-69. PubMed ID: 20708639
[TBL] [Abstract][Full Text] [Related]
6. Uptake of Al3+ into the N-lobe of human serum transferrin.
Kubal G; Mason AB; Sadler PJ; Tucker A; Woodworth RC
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):711-4. PubMed ID: 1497609
[TBL] [Abstract][Full Text] [Related]
7. Comparative binding study of aluminum and chromium to human transferrin. Effect of iron.
Moshtaghie AA; Ani M; Bazrafshan MR
Biol Trace Elem Res; 1992; 32():39-46. PubMed ID: 1375080
[TBL] [Abstract][Full Text] [Related]
8. Spectral studies on aluminum ion binding to the ligands with phenolic group(s): implications for the differences between N- and C-terminal binding sites of human serum apotransferrin.
Yang B; Feng J; Li Y; Gao F; Zhao Y; Wang J
J Inorg Biochem; 2003 Aug; 96(2-3):416-24. PubMed ID: 12888278
[TBL] [Abstract][Full Text] [Related]
9. Aluminum exchange between citrate and human serum transferrin and interaction with transferrin receptor 1.
Hémadi M; Miquel G; Kahn PH; El Hage Chahine JM
Biochemistry; 2003 Mar; 42(10):3120-30. PubMed ID: 12627980
[TBL] [Abstract][Full Text] [Related]
10. Spectroscopic studies of the interaction between alprazolam and apo-human serum transferrin as a drug carrier protein.
Karimian Amroabadi M; Taheri-Kafrani A; Heidarpoor Saremi L; Rastegari AA
Int J Biol Macromol; 2018 Mar; 108():263-271. PubMed ID: 29199122
[TBL] [Abstract][Full Text] [Related]
11. Visualized detection of apo-transferrin based on cyanine dye supramolecular assembly.
Lang Y; Shi L; Lan L; Zhao Z; Yang D; Fu Y; Tang Y; Zhang X
Spectrochim Acta A Mol Biomol Spectrosc; 2019 May; 215():334-339. PubMed ID: 30852280
[TBL] [Abstract][Full Text] [Related]
12. Spectral study on the binding of gadolinium ions with apoovotransferrin.
Wang JL; Li YQ; Yang BS
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Jul; 67(3-4):1101-5. PubMed ID: 17092766
[TBL] [Abstract][Full Text] [Related]
13. Tertiary structural changes associated with iron binding and release in hen serum transferrin: a crystallographic and spectroscopic study.
Thakurta PG; Choudhury D; Dasgupta R; Dattagupta JK
Biochem Biophys Res Commun; 2004 Apr; 316(4):1124-31. PubMed ID: 15044101
[TBL] [Abstract][Full Text] [Related]
14. Measurement of interaction behavior of six biologically important noble metal ions with the iron(III) binding protein, apo-transferrin, using mobility-shift affinity electrophoresis.
Alhazmi HA
Pharmazie; 2018 Mar; 73(3):143-149. PubMed ID: 29544561
[TBL] [Abstract][Full Text] [Related]
15. Spectral characterization of ruthenium (III) transferrin.
Kratz F; Messori L
J Inorg Biochem; 1993 Feb; 49(2):79-82. PubMed ID: 8384244
[TBL] [Abstract][Full Text] [Related]
16. Dynamic structure of human serum transferrin from transient electric birefringence experiments.
van Haeringen B; de Lange F; van Stokkum IH; Srai SK; Evans RW; van Grondelle R; Bloemendal M
Proteins; 1995 Oct; 23(2):233-40. PubMed ID: 8592704
[TBL] [Abstract][Full Text] [Related]
17. Structural consequences of binding of UO2(2+) to apotransferrin: can this protein account for entry of uranium into human cells?
Vidaud C; Gourion-Arsiquaud S; Rollin-Genetet F; Torne-Celer C; Plantevin S; Pible O; Berthomieu C; Quéméneur E
Biochemistry; 2007 Feb; 46(8):2215-26. PubMed ID: 17266333
[TBL] [Abstract][Full Text] [Related]
18. Steric restrictions on the binding of large metal ions to serum transferrin.
Harris WR; Yang B; Abdollahi S; Hamada Y
J Inorg Biochem; 1999 Sep; 76(3-4):231-42. PubMed ID: 10605839
[TBL] [Abstract][Full Text] [Related]
19. Steady-state and time-resolved fluorescence studies on wild type and mutant chromatium vinosum high potential iron proteins: holo- and apo-forms.
Sau AK; Chen CA; Cowan JA; Mazumdar S; Mitra S
Biophys J; 2001 Oct; 81(4):2320-30. PubMed ID: 11566801
[TBL] [Abstract][Full Text] [Related]
20. Use of spectroscopic, zeta potential and molecular dynamic techniques to study the interaction between human holo-transferrin and two antagonist drugs: comparison of binary and ternary systems.
Kabiri M; Amiri-Tehranizadeh Z; Baratian A; Saberi MR; Chamani J
Molecules; 2012 Mar; 17(3):3114-47. PubMed ID: 22410420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
